Jazz Pharmaceuticals plc - SHS USD (JAZZ)

CUSIP: G50871105

Q4 2021 13F Holders as of 31 Dec 2021

Type / Class
Equity / SHS USD
Total 13F shares
57,664,502
Share change
+190,385
Total reported value
$7,350,056,970
Put/Call ratio
213%
Price per share
$127.40
Number of holders
422
Value change
+$21,422,030
Number of buys
174
Number of sells
221

Quarterly Holders Quick Answers

What is CUSIP G50871105?
CUSIP G50871105 identifies JAZZ - Jazz Pharmaceuticals plc - SHS USD in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Jazz Pharmaceuticals plc - SHS USD (JAZZ) as of Q4 2021

As of 31 Dec 2021, Jazz Pharmaceuticals plc - SHS USD (JAZZ) was held by 422 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 57,664,502 shares. The largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, JPMORGAN CHASE & CO, WELLINGTON MANAGEMENT GROUP LLP, STATE STREET CORP, LSV ASSET MANAGEMENT, RENAISSANCE TECHNOLOGIES LLC, FMR LLC, Polaris Capital Management, LLC, and GOLDMAN SACHS GROUP INC. This page lists 423 institutional shareholders reporting positions in this security for the Q4 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.